Can Quetiapine Trigger Dissociation?
Yes, quetiapine can trigger dissociative symptoms including depersonalization and derealization, though this is a rare adverse effect documented in case reports rather than large-scale clinical trials.
Evidence for Quetiapine-Induced Dissociation
A published case report documents a 65-year-old male with schizophrenia who developed depersonalization-derealization syndrome specifically following quetiapine treatment 1.
The FDA label for quetiapine (Seroquel) does not list dissociative symptoms among its recognized adverse reactions, focusing instead on cognitive and motor impairment, somnolence, and anticholinergic effects 2.
Mechanism and Clinical Context
Quetiapine's active metabolite norquetiapine has moderate to strong anticholinergic activity at muscarinic receptors, which can contribute to cognitive disturbances and altered mental states 2.
The drug is documented to cause cognitive and motor impairment, with somnolence rates of 18-57% depending on indication, which may overlap phenomenologically with dissociative experiences 2.
Dissociative symptoms are more commonly precipitated by classic psychedelics and cannabis rather than atypical antipsychotics, and when they occur after drug exposure, they typically reflect underlying vulnerability to depersonalization-derealization disorder rather than direct drug toxicity 3.
Clinical Approach When Dissociation Occurs
Discontinue or reduce quetiapine if dissociative symptoms emerge, as the temporal relationship in the documented case suggests causality 1.
Evaluate for alternative causes including:
- Concurrent use of other serotonergic or anticholinergic medications that may interact with quetiapine 2
- Underlying anxiety disorders, depression, or personality disorders (the most common comorbidities with depersonalization-derealization disorder) 3
- Recent cannabis or psychedelic use, which are more established triggers 3
If dissociative symptoms persist beyond quetiapine discontinuation, consider that the drug may have catalyzed latent depersonalization-derealization disorder in a vulnerable individual rather than being the sole cause 3.
Important Caveats
The evidence linking quetiapine to dissociation consists of a single case report 1, making this an extremely rare phenomenon that should not be overstated.
Quetiapine showed no significant benefit for relapse prevention in cannabis-induced psychosis across all dose ranges in a large Swedish cohort study, suggesting limited efficacy in certain psychotic presentations where dissociative features may overlap 4.
The anticholinergic burden of quetiapine can worsen cognition and should be considered when patients report subjective experiences of unreality or detachment 2.